246 related articles for article (PubMed ID: 8011997)
1. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
[TBL] [Abstract][Full Text] [Related]
4. [The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases].
Allgayer B; Lukas P; Loos W; Kersting-Sommerhoff B
Rofo; 1993 May; 158(5):423-7. PubMed ID: 8490150
[TBL] [Abstract][Full Text] [Related]
5. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
6. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic 3D MR mammography using a rapid gradient-echo sequence].
Müller-Schimpfle M; Rieber A; Kurz S; Stern W; Claussen CD
Rofo; 1995 Jan; 162(1):13-9. PubMed ID: 7841394
[TBL] [Abstract][Full Text] [Related]
8. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging.
Nakashima R; Yamashita Y; Tomiguchi S; Tsuji A; Takahashi M
Radiat Med; 1996; 14(5):251-6. PubMed ID: 8988504
[TBL] [Abstract][Full Text] [Related]
9. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
10. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
12. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
[TBL] [Abstract][Full Text] [Related]
13. [Lymph node staging in cervix carcinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased-array body coil].
Heuck A; Scheidler J; Kimmig R; Müller-Lisse U; Steinborn M; Helmberger T; Reiser M
Rofo; 1997 Mar; 166(3):210-4. PubMed ID: 9156591
[TBL] [Abstract][Full Text] [Related]
14. [Dynamic imaging with magnetic resonance in the diagnosis of breast disease].
Ercolani P; Giovagnoni A; Giuseppetti G; Baldassarre S; De Nigris E; Amici F
Radiol Med; 1991 Oct; 82(4):422-6. PubMed ID: 1767046
[TBL] [Abstract][Full Text] [Related]
15. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
[TBL] [Abstract][Full Text] [Related]
16. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior].
Doringer E; Joos H; Forstner R; Schmoller H
Rofo; 1991 Apr; 154(4):357-63. PubMed ID: 1850149
[TBL] [Abstract][Full Text] [Related]
17. [Enhanced MRI of breast cancer smaller than 3 cm].
Ikeda Y; Narabayashi I; Yoshida S; Motohara T; Koizumi T; Ogawa K; Mieda C; Ueda E; Hirota S; Oshitani T
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Nov; 51(11):1314-23. PubMed ID: 1662800
[TBL] [Abstract][Full Text] [Related]
18. Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI.
Mirowitz SA; Totty WG; Lee JK
J Comput Assist Tomogr; 1992; 16(1):120-5. PubMed ID: 1729290
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-DTPA enhancement of VX-2 carcinoma of the rabbit kidney on T1 weighted magnetic resonance images.
Yancey JM; Ackerman N; Kaude JV; Googe RE; Fitzsimmons JR; Scott KN; Mancuso AA; Hackett RL; Hager DA; Caballero S
Acta Radiol; 1987; 28(4):479-82. PubMed ID: 2958067
[TBL] [Abstract][Full Text] [Related]
20. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
